Physician profile
Grace Chow
NPI 1285020271
$1,114.04
in general payments reported to CMS, 2019-2025
16 companies · $43.03 in 2025
The $43.03 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $12.88 · 2021: $146 · 2022: $565 · 2023: $228 · 2025: $43.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $199.95 | 2021-2023 | |
| Abbvie INC. | $174.01 | 2019-2023 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $155.47 | 2022 | |
| Hologic Sales and Service, LLC | $126.71 | 2022-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Coopersurgical, INC. | $85.72 | 2022-2023 | Paragard T 380a, Endosee |
| Exeltis, USA INC. | $78.21 | 2021-2023 | Slynd |
| Lupin INC. | $52.52 | 2019 | |
| Scynexis, INC. | $45.01 | 2022 | |
| Organon LLC | $44.96 | 2021-2023 | Nexplanon |
| Pfizer INC. | $36.35 | 2021-2022 | |
| Allergan, INC. | $31.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.27 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.81 | 2019 | |
| Astellas Pharma US INC | $13.70 | 2023 | Veozah |
| Myovant Sciences INC. | $13.21 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.